Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V A Miller

Showing results (51-60 of 53) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 53 results.
Leukemia|July 2, 2016
Patient-derived xenotransplants can recapitulate the genetic driver landscape of acute leukemiasK Wang, M Sanchez-Martin, X Wang, et al.
Blood Cancer Journal|February 25, 2017
Bi-allelic inactivation is more prevalent at relapse in multiple myeloma, identifying RB1 as an independent prognostic markerS S Chavan, J He, R Tytarenko, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 26, 2017
Hybrid capture-based genomic profiling of circulating tumor DNA from patients with estrogen receptor-positive metastatic breast cancerJ H Chung, D Pavlick, R Hartmaier, et al.
Pageof 6

Showing results (51-60 of 53) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 53 results.
Leukemia|July 2, 2016
Patient-derived xenotransplants can recapitulate the genetic driver landscape of acute leukemiasK Wang, M Sanchez-Martin, X Wang, et al.
Blood Cancer Journal|February 25, 2017
Bi-allelic inactivation is more prevalent at relapse in multiple myeloma, identifying RB1 as an independent prognostic markerS S Chavan, J He, R Tytarenko, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 26, 2017
Hybrid capture-based genomic profiling of circulating tumor DNA from patients with estrogen receptor-positive metastatic breast cancerJ H Chung, D Pavlick, R Hartmaier, et al.
Pageof 6